Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
476
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
05 Jul 2016 09:24
What the IPOs Completed in Korea Stock Exchange in 1H 2016 Reveal....
If you want to outperform the market, perhaps you should take a look at the IPO market in Korea. In the midst of difficult global IPO markets, the...
Douglas Kim
Follow
293 Views
Share
bearish
•
Celltrion Inc
•
12 Jun 2016 03:20
Study Highlights Hurdles to U.S. Uptake of Inflectra
A new study (abstract attached) presented at the European Union League Against Rheumatism (EULAR) Conference highlights one of the main hurdles to...
Kemp Dolliver, CFA
184 Views
Share
bullish
•
Thematic (Sector/Industry)
•
31 May 2016 15:45
Korea Stock Market Monthly Recap #2 - (May 2016)
Our portfolio of top picks were up on average 9.5% in May versus KOSPI which was down 0.5% in the same period. Our top picks in the Korean...
Douglas Kim
Follow
183 Views
Share
bearish
•
Celltrion Inc
•
17 May 2016 10:20
Why Be Optimistic if the Payers Are Cautious?
Recent comments from one of the largest health insurers in the U.S. reinforce our view that management's expectations for Remsima (U.S. name...
Kemp Dolliver, CFA
184 Views
Share
bearish
•
Thematic (Sector/Industry)
•
14 May 2016 07:55
What's All the Fuss About Quantitative Easing in Korea?
There have been lots of discussions in Korea's media about Korea's version of Quantitative Easing in the past several weeks, especially after...
Douglas Kim
Follow
182 Views
Share
First
Previous
90
91
92
93
94
95
96
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.35.0
x